669 related articles for article (PubMed ID: 29466296)
1. Sarcoma Spheroids and Organoids-Promising Tools in the Era of Personalized Medicine.
Colella G; Fazioli F; Gallo M; De Chiara A; Apice G; Ruosi C; Cimmino A; de Nigris F
Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29466296
[TBL] [Abstract][Full Text] [Related]
2. Modeling neoplastic disease with spheroids and organoids.
Zanoni M; Cortesi M; Zamagni A; Arienti C; Pignatta S; Tesei A
J Hematol Oncol; 2020 Jul; 13(1):97. PubMed ID: 32677979
[TBL] [Abstract][Full Text] [Related]
3. [Progress in prostate cancer study: 3D cell culture enables the ex vivo reproduction of tumor characteristics].
Tostivint V; Racaud-Sultan C; Roumiguié M; Soulié M; Gamé X; Beauval JB
Presse Med; 2017 Oct; 46(10):954-965. PubMed ID: 28967525
[TBL] [Abstract][Full Text] [Related]
4. Biomaterials-Based Approaches to Tumor Spheroid and Organoid Modeling.
Thakuri PS; Liu C; Luker GD; Tavana H
Adv Healthc Mater; 2018 Mar; 7(6):e1700980. PubMed ID: 29205942
[TBL] [Abstract][Full Text] [Related]
5. Short-term spheroid culture of primary colorectal cancer cells as an in vitro model for personalizing cancer medicine.
Jeppesen M; Hagel G; Glenthoj A; Vainer B; Ibsen P; Harling H; Thastrup O; Jørgensen LN; Thastrup J
PLoS One; 2017; 12(9):e0183074. PubMed ID: 28877221
[TBL] [Abstract][Full Text] [Related]
6. What role could organoids play in the personalization of cancer treatment?
Francies HE; Garnett MJ
Pharmacogenomics; 2015; 16(14):1523-6. PubMed ID: 26485224
[TBL] [Abstract][Full Text] [Related]
7. Design of spherically structured 3D in vitro tumor models -Advances and prospects.
Ferreira LP; Gaspar VM; Mano JF
Acta Biomater; 2018 Jul; 75():11-34. PubMed ID: 29803007
[TBL] [Abstract][Full Text] [Related]
8. [Spheroids to organoids: Solid cancer models for anticancer drug discovery].
Alzeeb G; Corcos L; Le Jossic-Corcos C
Bull Cancer; 2022 Jan; 109(1):49-57. PubMed ID: 34848046
[TBL] [Abstract][Full Text] [Related]
9. Three-Dimensional Patient-Derived
Gaebler M; Silvestri A; Haybaeck J; Reichardt P; Lowery CD; Stancato LF; Zybarth G; Regenbrecht CRA
Front Oncol; 2017; 7():203. PubMed ID: 28955656
[TBL] [Abstract][Full Text] [Related]
10. Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine.
Gilazieva Z; Ponomarev A; Rutland C; Rizvanov A; Solovyeva V
Cancers (Basel); 2020 Sep; 12(10):. PubMed ID: 32977530
[TBL] [Abstract][Full Text] [Related]
11. 3D Models of Sarcomas: The Next-generation Tool for Personalized Medicine.
Xu R; Chen R; Tu C; Gong X; Liu Z; Mei L; Ren X; Li Z
Phenomics; 2024 Apr; 4(2):171-186. PubMed ID: 38884054
[TBL] [Abstract][Full Text] [Related]
12. Liver organoids: a promising three-dimensional model for insights and innovations in tumor progression and precision medicine of liver cancer.
Chen Y; Liu Y; Chen S; Zhang L; Rao J; Lu X; Ma Y
Front Immunol; 2023; 14():1180184. PubMed ID: 37334366
[TBL] [Abstract][Full Text] [Related]
13. Tumor spheroid assembly on hyaluronic acid-based structures: A review.
Carvalho MP; Costa EC; Miguel SP; Correia IJ
Carbohydr Polym; 2016 Oct; 150():139-48. PubMed ID: 27312623
[TBL] [Abstract][Full Text] [Related]
14. Genome engineering of stem cell organoids for disease modeling.
Sun Y; Ding Q
Protein Cell; 2017 May; 8(5):315-327. PubMed ID: 28102490
[TBL] [Abstract][Full Text] [Related]
15. Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer.
Bhattacharya A; Alam K; Roy NS; Kaur K; Kaity S; Ravichandiran V; Roy S
J Exp Clin Cancer Res; 2023 Dec; 42(1):343. PubMed ID: 38102637
[TBL] [Abstract][Full Text] [Related]
16. Tumor organoid models in precision medicine and investigating cancer-stromal interactions.
Xu R; Zhou X; Wang S; Trinkle C
Pharmacol Ther; 2021 Feb; 218():107668. PubMed ID: 32853629
[TBL] [Abstract][Full Text] [Related]
17. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
Kondo J; Inoue M
Cells; 2019 May; 8(5):. PubMed ID: 31108870
[TBL] [Abstract][Full Text] [Related]
18. Three-dimensional (3D) culture in sarcoma research and the clinical significance.
Gao S; Shen J; Hornicek F; Duan Z
Biofabrication; 2017 Aug; 9(3):032003. PubMed ID: 28707624
[TBL] [Abstract][Full Text] [Related]
19. Preclinical tumor organoid models in personalized cancer therapy: Not everyone fits the mold.
Hu LF; Yang X; Lan HR; Fang XL; Chen XY; Jin KT
Exp Cell Res; 2021 Nov; 408(2):112858. PubMed ID: 34600901
[TBL] [Abstract][Full Text] [Related]
20. 3D Biomimetic Models to Reconstitute Tumor Microenvironment In Vitro: Spheroids, Organoids, and Tumor-on-a-Chip.
Li W; Zhou Z; Zhou X; Khoo BL; Gunawan R; Chin YR; Zhang L; Yi C; Guan X; Yang M
Adv Healthc Mater; 2023 Jul; 12(18):e2202609. PubMed ID: 36917657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
